Related Experiment Video
Updated: Aug 8, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Relationship Between Beta Cell Dysfunction and Severity of Disease Among Critically Ill Children: A STROBE-Compliant
Ping-Ping Liu1, Xiu-Lan Lu, Zheng-Hui Xiao
1From the Emergency Center of Hunan Children's Hospital (P-PL, X-LL, Z-HX, JQ) and Pediatric Medical Center of Hunan People's Hospital (Y-MZ), Changsha, Hunan, China.
Insights
Beta cell dysfunction in critically ill children is linked to increased disease severity and adverse outcomes. Assessing beta cell function is crucial for improving patient care in the Pediatric Intensive Care Unit (PICU).
Area of Science:
- Pediatric Critical Care Medicine
- Endocrinology
- Metabolic Disorders
Background:
- Beta cell dysfunction is a known prognostic factor in humans and animals.
- Its predictive value for disease severity in critically ill children remains largely unexamined.
Purpose of the Study:
- To investigate the association between beta cell dysfunction and disease severity in critically ill children.
- To determine if beta cell function predicts adverse outcomes in this population.
Main Methods:
- A prospective study of 1146 critically ill children admitted to the Pediatric Intensive Care Unit (PICU).
- Beta cell function assessed using Homeostasis Model Assessment (HOMA)-β, categorizing patients into four groups.
- Disease severity evaluated using Sequential Organ Failure Assessment (SOFA) and Pediatric Risk of Mortality (PRISM) III scores, and incidence of organ damage, septic shock, MODS, MV, and mortality.
- Logistic regression analysis used to assess the risk of poor outcomes.
Main Results:
- 70.41% of children exhibited HOMA-β < 100%.
- Declining HOMA-β correlated with decreased C-peptide and insulin levels.
- Higher SOFA and PRISM III scores were observed with declining HOMA-β.
- Reduced beta cell function (lower HOMA-β) was associated with increased risk of septic shock, MODS, mechanical ventilation (MV), and mortality, even after adjusting for confounders.
Conclusions:
- Beta cell dysfunction serves as an indicator of disease severity in critically ill children.
- Assessment of beta cell function is vital for mitigating adverse events in the PICU.
- This finding highlights the importance of monitoring metabolic status in pediatric critical care.
Abstract:
Although beta cell dysfunction has been proved to predict prognosis among humans and animals, its prediction on severity of disease remains unclear among children. The present study was aimed to examine the relationship between beta cell dysfunction and severity of disease among critically ill children.This prospective study included 1146 critically ill children, who were admitted to Pediatric Intensive Care Unit (PICU) of Hunan Children's Hospital from November 2011 to August 2013. Information on characteristics, laboratory tests, and prognostic outcomes was collected. Homeostasis model assessment (HOMA)-β, evaluating beta cell function, was used to divide all participants into 4 groups: HOMA-β = 100% (group I, n = 339), 80% ≤ HOMA-β < 100% (group II, n = 71), 40% ≤ HOMA-β < 80% (group III, n = 293), and HOMA-β < 40% (group IV, n = 443). Severity of disease was assessed using the worst Sequential Organ Failure Assessment (SOFA) score, Pediatric Risk of Mortality (PRISM) III score, incidence of organ damage, septic shock, multiple organ dysfunction syndrome (MODS), mechanical ventilation (MV) and mortality. Logistic regression analysis was used to evaluate the risk of developing poor outcomes among patients in different HOMA-β groups, with group I as the reference group.Among 1146 children, incidence of HOMA-β < 100% was 70.41%. C-peptide and insulin declined with the decrement of HOMA-β (P < 0.01). C-reactive protein and procalcitonin levels, rather than white blood cell, were significantly different among 4 groups (P < 0.01). In addition, the worst SOFA score and the worst PRISMIII score increased with declined HOMA-β. For example, the worst SOFA score in group I, II, III, and IV was 1.55 ± 1.85, 1.71 ± 1.93, 1.92 ± 1.63, and 2.18 ± 1.77, respectively. Furthermore, patients with declined HOMA-β had higher risk of developing septic shock, MODS, MV, and mortality, even after adjusting age, gender, myocardial injury, and lung injury. For instance, compared with group I, the multivariate-adjusted odds ratio (95% confidence interval) for developing septic shock was 2.17 (0.59, 8.02), 2.94 (2.18, 6.46), and 2.76 (1.18, 6.46) among patients in group II, III, and IV, respectively.Beta cell dysfunction reflected the severity of disease among critically ill children. Therefore, assessment of beta cell function is critically important to reduce incidence of adverse events in PICU.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetic Ketoacidosis l: Introduction

